Cargando…

Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma

Epilepsy at presentation is an independent favorable prognostic factor in glioblastoma (GBM). In this study, we analyze the oncologic signaling pathways that associate with epilepsy in human GBMs, and that can underlie this prognostic effect. Following ethical approval and patient consent, fresh fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berendsen, Sharon, Spliet, Wim G. M., Geurts, Marjolein, Van Hecke, Wim, Seute, Tatjana, Snijders, Tom J., Bours, Vincent, Bell, Erica H., Chakravarti, Arnab, Robe, Pierre A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356242/ https://www.ncbi.nlm.nih.gov/pubmed/30621209 http://dx.doi.org/10.3390/cancers11010041

Ejemplares similares

STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
por: Dubois, Nadège, et al.
Publicado: (2022)

Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates
por: Berendsen, Sharon, et al.
Publicado: (2019)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma
por: van Kessel, Emma, et al.
Publicado: (2022)

Early Surgery Prolongs Professional Activity in IDH Mutant Low-Grade Glioma Patients: A Policy Change Analysis
por: Robe, Pierre A., et al.
Publicado: (2022)

Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression Analysis
por: Dalemans, Diana J. Z., et al.
Publicado: (2021)

Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis
por: Arik, Yunus, et al.
Publicado: (2014)

The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma
por: Dankbaar, J. W., et al.
Publicado: (2015)

A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis
por: Alvarez, James V., et al.
Publicado: (2007)

International practice variation in perioperative laboratory testing in glioblastoma patients—a retrospective cohort study
por: Senders, Joeky T., et al.
Publicado: (2022)

Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma
por: Bassett, Emily A., et al.
Publicado: (2018)

Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors
por: Vermeulen, Jeroen F., et al.
Publicado: (2016)

Glioblastoma Multiforme in the Posterior Cranial Fossa in a Patient with Neurofibromatosis Type I
por: Broekman, Marike L. D., et al.
Publicado: (2009)

Novel Therapies in Glioblastoma
por: Perry, James, et al.
Publicado: (2012)

Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology
por: Becker, Aline P., et al.
Publicado: (2021)

Cognitive impairments are independently associated with shorter survival in diffuse glioma patients
por: van Kessel, Emma, et al.
Publicado: (2020)

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
por: van Kessel, Emma, et al.
Publicado: (2021)

Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3–4) Gliomas
por: Flies, Christina M., et al.
Publicado: (2022)

Will (177)Lu-DOTATATE Treatment Become More Effective in Salvage Meningioma Patients, When Boosting Somatostatin Receptor Saturation? A Promising Case on Intra-arterial Administration
por: Braat, A. J. A. T., et al.
Publicado: (2019)

Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and Resections
por: Müller, Domenique M.J., et al.
Publicado: (2019)

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
por: Vermeulen, Jeroen F., et al.
Publicado: (2017)

STAT3, HIF-1, glucose addiction and Warburg effect
por: Darnell, James E.
Publicado: (2010)

Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients
por: van Kessel, Emma, et al.
Publicado: (2022)

The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme
por: Wang, Enfeng, et al.
Publicado: (2014)

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review
por: van Westrhenen, Anouk, et al.
Publicado: (2018)

Long‐term seizure outcome after epilepsy surgery in patients with mild malformation of cortical development and focal cortical dysplasia
por: Veersema, Tim J., et al.
Publicado: (2018)

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
por: MAYER, ARNULF, et al.
Publicado: (2012)

IκBζ: an emerging player in cancer
por: Willems, Marie, et al.
Publicado: (2016)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

STAT3 or USF2 Contributes to HIF Target Gene Specificity
por: Pawlus, Matthew R., et al.
Publicado: (2013)

STAT3 and mTOR: co-operating to drive HIF and angiogenesis
por: Dodd, Kayleigh M., et al.
Publicado: (2015)

Data on vessel wall thickness measurements of intracranial arteries derived from human circle of Willis specimens
por: Harteveld, Anita A., et al.
Publicado: (2018)

The STAT3-Regulated Autophagy Pathway in Glioblastoma
por: Laribee, Ronald Nicholas, et al.
Publicado: (2023)

Roles of STAT3 in the pathogenesis and treatment of glioblastoma
por: Fu, Weijia, et al.
Publicado: (2023)

STAT3, p-STAT3 and HIF-1α are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinoma
por: SONG, YAN-YAN, et al.
Publicado: (2014)

PKM2, STAT3 and HIF-1α: The Warburg’s vicious circle
por: Demaria, Marco, et al.
Publicado: (2012)

Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?
por: DOBRAN, Mauro, et al.
Publicado: (2018)

Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
por: Lange, Falko, et al.
Publicado: (2021)

A phase 1–2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]
por: Robe, Pierre A, et al.
Publicado: (2006)

Central Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis
por: van Rooij, Josephus L. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5bcrt6p3fgf01q8eu3kha93i1